Question · Q4 2025
Matt Smith inquired about the reacceleration in smoke-free volume growth beyond 2026 compared to the current year's guidance, specifically asking how the U.S. market and expansion into existing IQOS markets are factored into the new medium-term targets.
Answer
CFO Emmanuel Babeau and Group CEO Jacek Olczak explained that the reacceleration is primarily driven by the normalization of Japan's multi-step excise tax changes post-2026, which will create more fiscal symmetry between heated tobacco products and cigarettes. They also highlighted the anticipated FDA authorization for ZYN Ultra in the U.S. to address portfolio asymmetry and the non-recurring nature of combustible excise increases in markets like India and Mexico. Innovation was also cited as a key driver.
Ask follow-up questions
Fintool can predict
PM's earnings beat/miss a week before the call


